U.S. regulators plan a major move to speed authorizations of vapes and tobacco pouches. The move comes despite lawmakers voicing concern about recent flavor approvals. The Food and Drug Administration aims to streamline its review process for e-cigarettes and oral nicotine products.

This could accelerate market entry for many products. Critics worry about youth appeal. The agency faces pressure to balance public health and industry demands.

The plan is expected to be announced soon. It marks a shift toward faster decisions on pending applications. Lawmakers have raised alarms over flavors that may attract minors.

The FDA says it will maintain safety standards. The change could affect companies like Juul Labs and Altria. Public health advocates are divided.

Some see benefits for adult smokers. Others fear increased youth use. The agency has struggled with a backlog of millions of applications.

This move aims to clear that logjam. It follows years of delays and legal battles. The FDA will prioritize products with strong evidence of reducing harm.

The industry welcomes the news. But concerns remain over enforcement and marketing restrictions. The plan is part of broader efforts to regulate nicotine products.

It reflects evolving science and policy. The outcome will shape the future of vaping in the U.S. The FDA will seek public comment before finalizing.